107 related articles for article (PubMed ID: 1670103)
1. [Differential diagnosis of hypercalcemia].
Elomaa I
Duodecim; 1990; 106(4):375-9. PubMed ID: 1670103
[No Abstract] [Full Text] [Related]
2. [The pathogenesis of the humoral hypercalcemia syndrome in patients with solid tumors].
Naafs MA; Silberbusch J
Ned Tijdschr Geneeskd; 1989 May; 133(21):1065-9. PubMed ID: 2662028
[No Abstract] [Full Text] [Related]
3. Hypercalcemia: diagnosis and therapy.
Canalis EM; Mundy GR; Raisz LG
Conn Med; 1977 Jan; 41(1):16-21. PubMed ID: 137799
[No Abstract] [Full Text] [Related]
4. Nonparathyroid humoral hypercalcemia in patients with neoplastic diseases.
Powell D; Singer FR; Murray TM; Minkin C; Potts JT
N Engl J Med; 1973 Jul; 289(4):176-81. PubMed ID: 4712989
[No Abstract] [Full Text] [Related]
5. [Extraparathyroid hypercalcemia].
Rizzoli R; Bonjour JP
Rev Prat; 1998 Jun; 48(11):1197-200. PubMed ID: 9781171
[TBL] [Abstract][Full Text] [Related]
6. [Calcium-alkali syndrome: update of an old clinical problem].
Fernández García M; Riancho Moral JA; Hernández Hernández JL
Med Clin (Barc); 2011 Sep; 137(6):269-72. PubMed ID: 21592535
[No Abstract] [Full Text] [Related]
7. Clinical inquiries. How should you evaluate elevated calcium in an asymptomatic patient?
Sharma B; Misicko NE; Hitchcock K; Neher JO
J Fam Pract; 2008 Apr; 57(4):267-9. PubMed ID: 18394361
[No Abstract] [Full Text] [Related]
8. Understanding hypercalcemia. Its metabolic basis, signs, and symptoms.
Inzucchi SE
Postgrad Med; 2004 Apr; 115(4):69-70, 73-6. PubMed ID: 15095538
[TBL] [Abstract][Full Text] [Related]
9. Overview of hypercalcemia of malignancy.
Solimando DA
Am J Health Syst Pharm; 2001 Nov; 58 Suppl 3():S4-7. PubMed ID: 11757205
[TBL] [Abstract][Full Text] [Related]
10. [The role of a parathyroid hormone analogue in the pathogenesis of malignant hypercalcemia].
Rizzoli R; Buchs B; Pizurki L; Caverzasio J; Sappino AP; Vadas L; Arlot M; Bonjour JP
Pathol Biol (Paris); 1990 Jun; 38(6):656-64. PubMed ID: 2197594
[TBL] [Abstract][Full Text] [Related]
11. Calcium metabolism in renal stone disease.
Ljunghall S; Backman U; Danielson BG; Fellström B; Johansson G; Wikström B
Scand J Urol Nephrol Suppl; 1980; 53():111-23. PubMed ID: 6937987
[No Abstract] [Full Text] [Related]
12. [Metabolic bone diseases: malignancy-associated hypercalcemia].
Hamada M; Takeda R
Nihon Rinsho; 1986 Nov; 44(11):2467-72. PubMed ID: 3546802
[No Abstract] [Full Text] [Related]
13. Humoral hypercalcemia of malignancy. The role of parathyroid hormone-related protein.
Insogna KL
Endocrinol Metab Clin North Am; 1989 Sep; 18(3):779-94. PubMed ID: 2673773
[TBL] [Abstract][Full Text] [Related]
14. The hypercalcemia of malignancy: pathogenesis and management.
Mundy GR; Martin TJ
Metabolism; 1982 Dec; 31(12):1247-77. PubMed ID: 6755168
[TBL] [Abstract][Full Text] [Related]
15. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
[TBL] [Abstract][Full Text] [Related]
16. [PTH-like tumor peptide and malignant hypercalcemia].
Rizzoli R; Bonjour JP
Schweiz Med Wochenschr; 1989 Aug; 119(33):1099-105. PubMed ID: 2552573
[TBL] [Abstract][Full Text] [Related]
17. Urinary cyclic AMP as an aid in the differential diagnosis of hypercalcemia.
Debacker M; Manderlier T; Nijs-Dewolf N; Six R; Corvilain J
Biomedicine; 1974 Aug; 21(8):338-41. PubMed ID: 4374265
[No Abstract] [Full Text] [Related]
18. [Parathyroid hormone-related peptide induced humoral hypercalcemia of malignancy].
Tfelt-Hansen J; Brixen KT; Mosekilde L; Schwarz P
Ugeskr Laeger; 2005 Feb; 167(8):924-6. PubMed ID: 15789851
[No Abstract] [Full Text] [Related]
19. Hypercalcemia of malignancy in the palliative care patient: a treatment strategy.
Kovacs CS; MacDonald SM; Chik CL; Bruera E
J Pain Symptom Manage; 1995 Apr; 10(3):224-32. PubMed ID: 7543127
[TBL] [Abstract][Full Text] [Related]
20. Hypercalcemia due to primary hyperparathyroidism or malignant disease. Evaluated by means of biochemical tests and the steroid suppression test.
Kvetny J; Orthman-Brask H; Frederiksen PK; Jest P; Jensen E; Jacobsen JG
Acta Med Scand; 1982; 212(3):163-6. PubMed ID: 7148507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
